31-45 of 457
Screening for Prediabetes in Youth with Obesity: Evaluating the TyG Index
Clinician's RoundtableScreening for Prediabetes in Youth with Obesity: Evaluating the TyG Index
Ryan Quigley
Obesity and Cancer Screening: National Trends and Disparities Revealed
Clinician's RoundtableObesity and Cancer Screening: National Trends and Disparities Revealed
Vance Albaugh, MD, PhD
Lifestyle Intervention and Bone Quality in Older Adults with Obesity
Clinician's RoundtableLifestyle Intervention and Bone Quality in Older Adults with Obesity
Identifying Hidden Risk: Metabolomic Patterns in Childhood Obesity
Clinician's RoundtableIdentifying Hidden Risk: Metabolomic Patterns in Childhood Obesity
EASD Highlights: Prediabetes Diagnosis, Prevalence, Misclassification Risks, and the Potential for Remission
Diabetes and EndocrinologyEASD Highlights: Prediabetes Diagnosis, Prevalence, Misclassification Risks, and the Potential for Remission
Femke Rutters, PhD
Managing Cholesterol and Triglyceride Levels: Targeted Nutritional Approaches
Heart MattersManaging Cholesterol and Triglyceride Levels: Targeted Nutritional Approaches
- advertisement
Risk of RVO in Type 2 Diabetes: GLP-1 Receptor Agonists Versus DPP-4 Inhibitors
Eye on Ocular HealthRisk of RVO in Type 2 Diabetes: GLP-1 Receptor Agonists Versus DPP-4 Inhibitors
Marlene Mimi Maeusli, PhD.
PRP Scaffolds in Chronic Wound Care: A Move Toward Regenerative Solutions
Clinician's RoundtablePRP Scaffolds in Chronic Wound Care: A Move Toward Regenerative Solutions
Evaluating NIRF Imaging in Hard-to-Heal Lower Leg Wounds
Clinician's RoundtableEvaluating NIRF Imaging in Hard-to-Heal Lower Leg Wounds
Optimizing Outcomes in Diabetic Limb Preservation
Clinician's RoundtableOptimizing Outcomes in Diabetic Limb Preservation
Paul J. Kim, DPM, MS, FACFAS
New-Onset Ketosis-Prone Diabetes in an Adult with Spinal Muscular Atrophy Type III
NeuroFrontiersNew-Onset Ketosis-Prone Diabetes in an Adult with Spinal Muscular Atrophy Type III
Navigating Gastrointestinal Impacts of GLP-1 Receptor Agonists
GI InsightsNavigating Gastrointestinal Impacts of GLP-1 Receptor Agonists
Peter Buch, MD, FACG, AGAF, FACP
Michael Camilleri, MD
- advertisement
Novel Therapies in Managing Patients With Cardiovascular-Kidney-Metabolic Syndrome and Heart Failure
Broadcast ReplayNovel Therapies in Managing Patients With Cardiovascular-Kidney-Metabolic Syndrome and Heart Failure
Riccardo Maria Inciardi, MD, PhD
Cristina Gavina, MD, PhD
Giuseppe Galati, MD
Diabetes and COVID-19: New Findings on the Systemic Burden
Clinician's RoundtableDiabetes and COVID-19: New Findings on the Systemic Burden
Semaglutide improves walking distance, symptoms and QoL in patients with PAD and T2D
ACC Action CenterSemaglutide improves walking distance, symptoms and QoL in patients with PAD and T2D
Marc Bonaca, MD
